The source of increased plasma potassium following succinylcholine

Area of Science:

• Anesthesiology
• Pharmacology
• Clinical Biochemistry

Background:

• Succinylcholine administration is known to cause hyperkalemia.
• The extent of hyperkalemia can be influenced by co-administered anesthetic agents and patient conditions.

Purpose of the Study:

• To investigate the factors influencing succinylcholine-induced hyperkalemia.
• To compare the effects of Althesin versus thiopental as induction agents on potassium levels.
• To identify patient populations at higher risk for severe hyperkalemia.

Main Methods:

• Plasma potassium levels were measured in patients receiving succinylcholine with different induction agents (Althesin, thiopental) and anesthetic agents (halothane).
• Creatine phosphokinase (CPK) enzyme activity was assessed to correlate with muscle trauma.
• The effect of tubocurarine pretreatment on potassium changes was evaluated.

Main Results:

• Greater increases in plasma potassium were observed with Althesin compared to thiopental.
• Halothane anesthesia exacerbated the potassium rise.
• Pretreatment with tubocurarine reduced the magnitude of hyperkalemia.
• Increased CPK activity confirmed muscle trauma as the source of potassium release.

Conclusions:

• The rise in plasma potassium following succinylcholine is primarily due to muscle trauma during fasciculation.
• Althesin and halothane should be used with caution alongside succinylcholine, particularly in patients with chronic catabolic states.
• Avoiding this combination in high-risk patients is crucial to prevent potentially fatal cardiac dysrhythmias.